Lexaria Bioscience Corp WT (LEXXW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEXXW | AZN | AMGN | GILD | BMY |
| Company | Lexaria Bioscience Corp WT | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0009 | 190.33 | 368.27 | 143.50 | 59.92 |
| High | 0.0045 | 195.79 | 378.82 | 146.92 | 60.64 |
| Low | 0.0009 | 189.35 | 366.53 | 143.49 | 59.25 |
| Latest | 0.0012 | 194.95 | 376.97 | 146.63 | 60.63 |
| Change | -0.0041 | +0.73 | +7.44 | +2.70 | +0.34 |
| % Change | -77.36% | +0.38% | +2.01% | +1.88% | +0.56% |
| Volume | 283,100 | 1,875,080 | 2,720,000 | 5,210,400 | 10,964,650 |
| 20-Day Average Volume | 47,660 | 2,278,035 | 2,690,915 | 7,473,020 | 12,973,885 |
| Previous Close | 0.0053 | 194.22 | 369.53 | 143.93 | 60.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0113 | 202.53 | 375.80 | 149.56 | 60.92 |
| 20-Day Raw Stochastic | 1.05% | 30.76% | 52.72% | 26.58% | 38.29% |
| 20-Day Relative Strength | 38.30 | 48.88 | 57.01 | 54.59 | 57.02 |
| Weighted Alpha | -90.88 | +31.12 | +28.96 | +38.44 | +15.60 |
| Today's Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -78.57% since 01/06/26 | -4.31% since 03/02/26 | -2.26% since 03/02/26 | -2.27% since 03/02/26 | -2.74% since 03/02/26 |
| Low | 0.0009 on 01/13/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 0.0099 on 01/07/26 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | -95.71% since 12/12/25 | +3.69% since 02/09/26 | +0.31% since 02/09/26 | -3.33% since 02/09/26 | -0.23% since 02/09/26 |
| Low | 0.0009 on 01/13/26 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 0.0296 on 12/15/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -96.91% since 10/13/25 | +8.52% since 12/09/25 | +20.11% since 12/09/25 | +22.85% since 12/09/25 | +19.70% since 12/09/25 |
| Low | 0.0009 on 01/13/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 0.0700 on 11/13/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -99.11% since 07/11/25 | +20.01% since 09/09/25 | +34.65% since 09/09/25 | +26.67% since 09/09/25 | +28.37% since 09/09/25 |
| Low | 0.0009 on 01/13/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.1935 on 07/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 301,217,344 | 199,201,792 | 178,677,728 | 122,779,024 |
| Shares Outstanding, K | N/A | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 710,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,900,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,595,007 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | N/A | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | N/A | 21.56 | 16.82 | 17.81 | 9.88 |